Lacosamide 31722-0815
Product NDC
31722-0815- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 17, 2022
- Listing Expires
- December 31, 2027
- Application
- ANDA204787
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 200 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(4)
500 TABLET, FILM COATED in 1 BOTTLE (31722-815-05)
180 TABLET, FILM COATED in 1 BOTTLE (31722-815-18)
100 TABLET, FILM COATED in 1 BLISTER PACK (31722-815-32)
60 TABLET, FILM COATED in 1 BOTTLE (31722-815-60)